Bio-Rad Laboratories Inc Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$568.72 | $591.94 | 8.58% | 1 | $217.09B |
| DHR | Danaher | Outperform |
10
|
$246.62 | $260.33 | 9.89% | 4 | $182.67B |
| A | Agilent Technologies | Outperform |
10
|
$137.04 | $138.82 | 10.55% | 10 | $40.16B |
| MTD | Mettler-Toledo International | Hold |
13
|
$1.23k | $1.12k | 0.02% | 0 | $26.30B |
| ILMN | Illumina | Outperform |
16
|
$123.05 | $159.28 | 21.90% | 9 | $19.60B |
| WAT | Waters | Hold |
15
|
$309.04 | $323.50 | 6.78% | 2 | $18.33B |
| AVTR | Avantor | Outperform |
16
|
$24.23 | $23.25 | 15.56% | 19 | $16.46B |
| PKI | PerkinElmer | Outperform |
16
|
$102.47 | $121.84 | 20.89% | 1 | $12.66B |
| BRKR | Bruker | Outperform |
16
|
$78.01 | $73.64 | 16.01% | 1 | $11.34B |
| COHR | Coherent | - |
12
|
$33.97 | $258.00 | -100.00% | 0 | $6.61B |
| PACB | Pacific Biosciences of Califor... | Outperform |
9
|
$1.65 | $12.67 | 112.12% | 4 | $449.37M |
| LAB | Standard BioTools | Buy |
11
|
$2.48 | $4.00 | 41.13% | 1 | $948.50M |
| HBIO | Harvard Bioscience | Buy |
14
|
$3.82 | $7.00 | 83.25% | 2 | $191.82M |
| EQTL | Equitech International | - |
0
|
$1.40 | $0.00 | -100.00% | 0 | $2.56M |
| ASPT | Haber | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.02M |
| MDIT | Medite Cancer Diagnostics | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.01M |
| OMRX | Orthometrix | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
| LFPI | LifePoint | - |
0
|
$0.00 | $5.50 | 0.00% | 0 | $0.00M |